Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy
- 1 April 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 32 (4), 307-313
- https://doi.org/10.1097/inf.0b013e31827bd1b0
Abstract
Background: The duration of protection after hepatitis B vaccination in early infancy is unclear and may be related to vaccination schedule, dosage, vaccine type and population characteristics. Factors potentially influencing waning immunity were assessed. Methods: A systematic review was performed. The main outcomes were prevalence of anti-hepatits B antibodies >= 10 mIU/mL after primary or booster vaccination. Factors potentially influencing protection were assessed in an adjusted random-effects meta-analysis model by age for both outcomes. Results of both meta-analyses were combined in a prognostic model. Results: Forty-six studies reporting on the anti-hepatits B antibodies >= 10 mIU/mL 5 to 20 years after primary immunization and 29 on booster response were identified. The adjusted meta-analyses identified maternal carrier status (odds ratio [OR]: 2.37 [1.11; 5.08]), lower vaccine dosage than presently recommended (OR: 0.14 [0.06; 0.30]) and gap time between last and preceding dose of the primary vaccine series (OR: 0.44 [0.22; 0.86]) as determinants for persistence of anti-hepatits B antibodies >= 10. A lower vaccine dosage was also associated with failure to respond to booster (OR: 0.20 [0.10; 0.38]). The prognostic model predicted long-term protection of 90% [77%; 100%] at the age of 17 years for offspring of noncarrier mothers vaccinated with a presently recommended dose and vaccination schedule. Conclusions: Based on meta-analyses, predictors of waning immunity after hepatitis B vaccination in infancy could be identified. A prognostic model for long-term protection after hepatitis B vaccination in infancy was developed.Keywords
This publication has 58 references indexed in Scilit:
- Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccinationVaccine, 2011
- Switched memory B cells maintain specific memory independently of serum antibodies: The hepatitis B exampleEuropean Journal of Immunology, 2011
- Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at BirthThe Pediatric Infectious Disease Journal, 2008
- Assessment of Anti-HBs Antigen in 6- to 9-Year-Old Children Routinely Vaccinated via Vaccination Program in IranMedical Principles and Practice, 2007
- Long-Term Follow-Up of Hepatitis B Surface Antibody Levels in Subjects Receiving Universal Hepatitis B Vaccination in Infancy in an Area of Hyperendemicity: Correlation between Radioimmunoassay and Enzyme ImmunoassayClinical and Vaccine Immunology, 2005
- Hepatitis B Vaccination in High‐Risk Infants: 10‐Year Follow‐UpThe Journal of Infectious Diseases, 1999
- Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigenHepatology, 1999
- Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombin`ant vaccineResearch in Virology, 1997
- Twelve-year follow-up study of hepatitis B immunization of Senegalese infantsJournal of Hepatology, 1994
- Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicityJournal of Medical Virology, 1994